Alexander Yaw Fui Chung

机构：SingHealth, National University of Singapore, Singapore General Hospital, Duke-NUS Medical School, National Cancer Centre Singapore · ORCID：0000-0002-4598-6139

发表论文 223 篇 · 总被引 6742 次 · h-index 44

代表论文

• Alnuctamab (ALNUC; BMS-986349; CC-93269), a 2+1 B-Cell Maturation Antigen (BCMA) × CD3 T-Cell Engager (TCE), Administered Subcutaneously (SC) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 First-in-Human Clinical Study (2023 · Blood · 被引 33)
• Targeting Treg–fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinoma (2025 · Gut · 被引 27)
• CD38 marks the exhausted CD8+ tissue-resident memory T cells in hepatocellular carcinoma (2023 · Frontiers in Immunology · 被引 16)
• P883: ALNUCTAMAB (ALNUC; BMS-986349; CC-93269), A BCMA × CD3 T-CELL ENGAGER, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): LATEST RESULTS FROM A PHASE 1 FIRST-IN-HUMAN CLINICAL STUDY (2023 · HemaSphere · 被引 15)
• Atypical memory B cells acquire Breg phenotypes in hepatocellular carcinoma (2025 · JCI Insight · 被引 10)
• 756P First-in-human phase I study of a novel claudin 6 (CLDN6) targeted antibody drug conjugate (ADC) TORL-1-23 (2023 · Annals of Oncology · 被引 10)